CaroGen Company

CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.

Total Funding: 1550000
Headquarters: Hamden, Connecticut, United States
Funding Status: Seed
Employee Number: 1-10
Estimated Revenue: Less than $1M
Last Funding Type: Grant
Last Funding Date: 2019-03-27
Investors Number: 2
Founded Date: 2012-01-01
Industry: Viral Vectors